Immatics N.V. (NASDAQ:IMTX) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St.05-15

It's shaping up to be a tough period for Immatics N.V. (NASDAQ:IMTX), which a week ago released some disappointing quarterly results that could have a notable impact on how the market views the stock....

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2635081883?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","is_english":true,"pubTime":"2026-05-15 18:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635081883","market":"nz","top_or_hot":-1,"title":"Immatics N.V. (NASDAQ:IMTX) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates","media":"Simply Wall St.","content":"<div>\n<p>It's shaping up to be a tough period for Immatics N.V. (NASDAQ:IMTX), which a week ago released some disappointing quarterly results that could have a notable impact on how the market views the stock....</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-imtx/immatics/news/immatics-nv-nasdaqimtx-just-released-its-first-quarter-resul\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Immatics N.V. (NASDAQ:IMTX) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nImmatics N.V. (NASDAQ:IMTX) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-15 18:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-imtx/immatics/news/immatics-nv-nasdaqimtx-just-released-its-first-quarter-resul><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's shaping up to be a tough period for Immatics N.V. (NASDAQ:IMTX), which a week ago released some disappointing quarterly results that could have a notable impact on how the market views the stock....</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-imtx/immatics/news/immatics-nv-nasdaqimtx-just-released-its-first-quarter-resul\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GPIQ","symbol_name":"GOLDMAN SACHS NASDAQ 100 CORE PREMIUM INCOME ETF","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-imtx/immatics/news/immatics-nv-nasdaqimtx-just-released-its-first-quarter-resul","article_id":"2635081883","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-imtx/immatics/news/immatics-nv-nasdaqimtx-just-released-its-first-quarter-resul","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2635081883","pubTimestamp":1778842736,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"It's shaping up to be a tough period for Immatics N.V. ( NASDAQ:IMTX ), which a week ago released some disappointing...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"GPIQ":"GOLDMAN SACHS NASDAQ 100 CORE PREMIUM INCOME ETF","BK4139":"生物科技","FTEC":"Fidelity MSCI Information Techno","NVIW.SI":"NVDA 3xLongSG261006","SQQQ":"纳指三倍做空ETF","QQQ":"纳指100ETF",".IXIC":"NASDAQ Composite","QQQA":"ProShares Nasdaq-100 Dorsey Wright Momentum ETF","JEPQ":"JPMorgan Nasdaq Equity Premium Income ETF","QLD":"2倍做多纳斯达克100指数ETF-ProShares","NDX":"纳斯达克100指数","TECS":"Direxion Daily Technology Bear 3X Shares","QQQE":"Direxion NASDAQ-100 Equal Weighted Index Shares","IMTX":"Immatics N.V.","QYLG":"Nasdaq 100 Covered Call & Growth ETF","QQQY":"Defiance Nasdaq 100 Enhanced Options & 0DTE Income ETF","QID":"两倍做空纳斯达克指数ETF-ProShares","PSQ":"做空纳斯达克100指数ETF-ProShares","QDTE":"Roundhill N-100 0DTE Covered Call Strategy ETF","TQQQ":"纳指三倍做多ETF","QQQJ":"Invesco NASDAQ Next Gen 100 ETF","ONEQ":"Fidelity NASDAQ Composite Index ETF","TQQY":"GraniteShares YieldBOOST QQQ ETF","QQQM":"NASDAQ100指数ETF-Invesco","IYW":"美国科技ETF-iShares"},"translate_title":"Immatics N.V.（纳斯达克：IMTX）刚刚发布了第一季度业绩，分析师正在更新他们的预测","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/f7353c893d17c1b2c957f37638599373","symbols_score_info":{"QQQY":0.6,"NVIW.SI":0.6,"QDTE":0.6,"FTEC":0.6,"QQQM":0.6,"TECS":0.6,"IYW":0.6,"PSQ":0.6,"SQQQ":0.6,"NDX":0.6,".IXIC":1.5,"TQQQ":0.6,"NQmain":0.6,"QQQA":0.6,"QQQE":0.6,"ONEQ":0.6,"JEPQ":0.6,"TQQY":0.6,"IMTX":1.5,"GPIQ":0.6,"MNQmain":0.6,"QQQJ":0.6,"QQQ":0.6,"QLD":0.6,"QYLG":0.6,"QID":0.6},"content_text":"It's shaping up to be a tough period for Immatics N.V. (NASDAQ:IMTX), which a week ago released some disappointing quarterly results that could have a notable impact on how the market views the stock.      The numbers were weak, with revenues of €7.8m coming in 14% short of analyst estimates. Statutory losses were €0.44 per share, 6.5% larger than what the analysts expected.     Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual.  With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.NasdaqCM:IMTX Earnings and Revenue Growth May 15th 2026 After the latest results, the nine analysts covering Immatics are now predicting revenues of €41.9m in 2026. If met, this would reflect a solid 12% improvement in revenue compared to the last 12 months.      Per-share losses are predicted to creep up to €1.74.       Yet prior to the latest earnings, the analysts had been forecasting revenues of €37.2m and losses of €1.60 per share in 2026.         So there's been quite a change-up of views after the recent consensus updates, with the analysts significantly increasing their revenue forecasts while also expecting losses per share to increase. It looks like the top line growth will not be achieved without incremental costs.      View our latest analysis for Immatics   The consensus price target stayed unchanged at US$18.78, seeming to suggest that higher forecast losses are not expected to have a long term impact on the valuation.        Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation.  Currently, the most bullish analyst values Immatics at US$25.00 per share, while the most bearish prices it at US$12.20.   This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.      These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Immatics' past performance and to peers in the same industry. It's clear from the latest estimates that Immatics' rate of growth is expected to accelerate meaningfully, with the forecast 17% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 5.8% p.a. over the past five years.    Compare this with other companies in the same industry, which are forecast to see revenue growth of 22% annually.  So it's clear that despite the acceleration in growth, Immatics is expected to grow meaningfully slower than the industry average.     AdvertisementThe Bottom Line  The most important thing to note is the forecast of increased losses next year, suggesting all may not be well at Immatics.        They also upgraded their revenue estimates for next year, even though it is expected to grow slower than the wider industry.       The consensus price target held steady at US$18.78, with the latest estimates not enough to have an impact on their price targets.   With that said, the long-term trajectory of the company's earnings is a lot more important than next year.   At Simply Wall St, we have a full range of analyst estimates for Immatics going out to 2028, and you can see them free on our platform here..  Plus, you should also learn about the   1 warning sign  we've spotted with Immatics .  New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2635081883","isCrawlerRequest":true}